SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Strawn, W. B
Right arrow Articles by Ferrario, C. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strawn, W. B
Right arrow Articles by Ferrario, C. M
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Editorial

Novel mechanisms linking angiotensin II and early atherogenesis

William B Strawn

Hypertension and Vascular Disease Center, Wake Forest, University School of Medicine Winston-Salem, North Carolina 27157 USA

Richard H Dean

Hypertension and Vascular Disease Center, Wake Forest, University School of Medicine Winston-Salem, North Carolina 27157 USA

Carlos M Ferrario

Hypertension and Vascular Disease Center, Wake Forest, University School of Medicine Winston-Salem, North Carolina 27157 USA, cferrari@ wfubmc.edu

Key Words: angiotensin II • losartan • atherosclerosis • monocyte • AT1 • CD11b

References

  • Ross R. Atherosclerosis--an inflammatory disease New England Journal of Medicine 1999; 14;340(2):115-26.[Free Full Text]
  • Gerrity RG The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. American Journal of Pathology 1981;103(2):181-90.[Abstract]
  • Gerrity RG, Goss JA, Soby L. Control of monocyte recruitment by chemotactic factor(s) in lesion-prone areas of swine aorta. Arteriosclerosis 1985; 5(1):55-66.[Abstract/Free Full Text]
  • Beall CJ, Breckenridge SM, Chakravarty L., Kolattukudy PE Expression of human monocyte chemoattractant protein-1 in the yeast Pichia pastoris. Protein Expression & Purification 1998;12(2):145-50.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Smyth S., Joneckis C., Parise L. Regulation of vascular integrins. Blood 1993; 81(11):2827-43.[Free Full Text]
  • Strawn W., Gallagher P., Tallant E., Ganten D., Ferrario CM Angiotensin AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats. J Cardiovasc Pharmacol 1999;33:341-51.1.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sugano M.,Makino N.,Yanaga T. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits. Athero 1996;127:123-9.[CrossRef]
  • Zimmerman B., Dunham E.Tissue renin-angiotensin system: a site of drug action? Ann Rev Pharmacol Toxicol 1997;37:53-69.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kleinert S. HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation. Lancet 1999;354(9181):841.[Web of Science][Medline] [Order article via Infotrieve]
  • Dickstein K., Kjekshus J. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan. American Journal of Cardiology 1999;83(4):477-81. 1.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Strawn W., Chappell MC, Dean RH, Kivlighn SD, Ferrario CM Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation 2000;101(in press).
  • Chisi JE, Wdzieczak-Bakala J.,Thierry J., Briscoe CV, Riches AC Captopril inhibits the proliferation of hematopoietic stem and progenitor cells in murine long-term bone marrow cultures. Stem Cells 1999;17(6):339-44.[Web of Science][Medline] [Order article via Infotrieve]
  • Diet F., Pratt RE, Berry GJ, Momose N., Gibbons GH, Dzau VJ - Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996 Dec 1;94(11):2756-67.[Abstract/Free Full Text]
  • Ohishi M., Ueda M., Rakugi H. et al. Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans. Journal of Hypertension 1997;15(11):1295-302.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ohishi M., Ueda M., Rakugi H. et al. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation 1997;96(10):3328-37.[Abstract/Free Full Text]
  • Berkenboom G. Unstable atherosclerotic plaque. Pathophysiology and therapeutic guidelines. Acta Cardiologica 1998;53(4):235-41.[Web of Science][Medline] [Order article via Infotrieve]
  • Ford CM, Li S., Pickering JG Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT1-receptor, transforming growth factor-beta, and tyrosine phosphorylation. Arteriosclerosis, Thrombosis & Vascular Biology 1999;19(8):1843-51.1.[Abstract/Free Full Text]
  • Weitkamp B., Cullen P., Plenz G., Robenek H., Rauterberg J. Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque. FASEB Journal 1999;13(11):1445-57.[Abstract/Free Full Text]
  • Dixon IM, Ju H., Reid NL, Scammell-La FT, Werner JP, Jasmin G. Cardiac collagen remodeling in the cardiomyopathic Syrian hamster and the effect of losartan. Journal of Molecular & Cellular Cardiology 1997;29(7):1837-50.[CrossRef]
  • Fukuhara M., Geary RL, Diz DI et al. Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. Hypertension 2000;35(S1,part2):353-9. 21.[Abstract/Free Full Text]
  • Keidar S. Angiotensin, LDL peroxidation and atherosclerosis. Life Sci 1998;63:111.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ferrario CM, Deitch JS, Dean RH, Strawn WB Hypertension and atherosclerosis: a mechanistic understanding of disease progression. Cardiovasc Risk Factors 1996;6(6):1-12.
  • Peeters AC, Netea MG, Kullberg BJ,ThienT., van der Meer JW The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology 1998;94(3):376-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kim JA, Berliner JA, Nadler JL. Angiotensin II increases monocyte binding to endothelial cells. Biochem Biophys Res Comm 1996;226(3):862-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wiener J., Lombardi DM, Su JE, Schwartz SM Immunohistochemical and molecular characterization of the differential response of the rat mesenteric microvasculature to angiotensin-II infusion. J Vasc Res 1996;33:195-208.[Web of Science][Medline] [Order article via Infotrieve]
  • Nickenig G., Jung O., Strehlow K. et al. Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am J Physiol 1997;272:H2701-H2707[Web of Science][Medline] [Order article via Infotrieve]
  • Nickenig G., Sachindis A., Michaelsen F., Böhm M., Seewald S., Vetter H. Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circ 1997;95(2):473-8.[Abstract/Free Full Text]
  • Keidar S., Kaplan M., Aviram M. Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation. Arterioscler Throm Vasc Biol 1996;16(1):97-105.[Abstract/Free Full Text]
  • Nakashima Y., Raines E., Plump A., Breslow J., Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterio Thromb Vasc Biol 1998;18:842-51.1.[Abstract/Free Full Text]
  • Martin T.,Cardarelli P., Parry G., Felts K., Cobb R. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depend on the cooperative action of NF-{kappa}B and AP-1. Eur J Immunol 1997;27:1091-7.[Web of Science][Medline] [Order article via Infotrieve]
  • Hernandez-Presa M., Bustos C., Ortego M. et al. Angtiotensin-converting enzyme prevents arterial nuclear factor kappa-B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997;95:1532-41.[Abstract/Free Full Text]
  • Gräfe M.,Auch-Schwelk W., Zakrzewicz A. et al. Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res 1997;81:804-11.[Abstract/Free Full Text]
  • Pal A., Ueland T., Muller F. et al. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circ 1998;97:1136-43.[Abstract/Free Full Text]
  • De Caterina R., Basta G., Lazzarini G. et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterio Thromb Vasc Biol 1997;17:2646-54.[Abstract/Free Full Text]
  • Morisaki N., Saito I.,Tamura K. et al. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Athero 1997;131:43-8.[CrossRef]
  • Peter K., Nawroth P., Conradt C. et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterio Thromb Vasc Biol 1997;17:505-12.[Abstract/Free Full Text]
  • Stary HC, Chandler AB, Glagov S. et al. A definition of initial fatty streak and intermediate lesions of atherosclerosis. Arterioscler Thromb 1994;14(5):840-56.[Abstract/Free Full Text]
  • Chobanian AV, Haudenschild CC, Nickerson C., Drago R. Anti-atherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1990;1:327-31.
  • Chobanian AV, Haudenschild CC, Nickerson C., Hope S.Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1992;20:473-7.[Abstract/Free Full Text]
  • Hope S., Brecher P., Chobanian AV Comparison of the effects of AT1-receptor blockade and angiotensin converting enzyme inhibtion on atherosclerosis. Am J Hyperten 1999;12:28-34.[Web of Science][Medline] [Order article via Infotrieve]
  • Keidar S.,Attias J., Smith J., Breslow J., Hayek T. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Comm 1997;236:622-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Smith JD, Breslow JL The emergence of mouse models of atherosclerosis and their relevance to clinical research. Journal of Internal Medicine 1997;242(2):99-109.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Aliev G., Burnstock G. - Watanabe rabbits with heritable hypercholesterolemia: a model of atherosclerosis. Histology & Histopathology 1998; 13(3):797-8177.
  • Clarkson TB Nonhuman primate models of atherosclerosis. Laboratory Animal Science 1998; 48(6):569-722.[Web of Science][Medline] [Order article via Infotrieve]
  • Best RG, Diamond D., Crawford E. et al. Baboon/human homologies examined by spectral karyotyping (SKY): a visual comparison. Cytogenetics & Cell Genetics 1998;82(1-2):83-7.[CrossRef]
  • Clarkson TB, Hughes CL, Klein KP The nonhuman primate model of the relationship between gonadal steroids and coronary heart disease. Progress in Cardiovascular Diseases 1995;38(3):189-98.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Weingand KW Atherosclerosis research in cynomolgus monkeys (Macaca fascicularis). Experimental & Molecular Pathology 1989;50(1):1-155.[CrossRef]
  • Wagner J., Schwenke D., Zhang L., Applebaum-Bowden D., Bagdade J., Adams M. Effects of short-term hormone replacement therapies on low-density lipoprotein metabolism in cynomolgus monkeys. Arterio Thromb Vasc Biol 1997;17:1128-34. 49. Song K., Shiota N.,Takai S. et al. Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed cynomolgus monkeys. Athero 1998;138:171-82.[CrossRef]
  • Soejima H., Ogawa H.,Yasue H. et al. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction. Journal of the American College of Cardiology 1999;34(4):983-8.[Abstract/Free Full Text]
  • Dawson TC, Kuziel WA, Osahar TA, Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 1999;143(1):205-11.1.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Aiello RJ, Bourassa PA, Lindsey S. et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis & Vascular Biology 1999;19(6):1518-25.[Abstract/Free Full Text]
  • Chen XL,Tummala PE, Olbrych MT,Alexander RW, Medford RM. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circulation Research 1998;83(9):952-9.[Abstract/Free Full Text]
  • Raiden S., Giordano M.,Andonegui G. et al. Losartan, a selective inhibitor of subtype AT1-receptors for angiotensin II, inhibits the binding of N-formylmethiolnylleucyl-phenylalanine to neutrophil receptors. JPET 1997;281(2):624-8.[Abstract/Free Full Text]
  • Meuret G., Bammert J., Hoffmann G. Kinetics of human monocytopoiesis. Blood 1974;44(6):801-16.[Abstract/Free Full Text]
  • Otani I.,Akari H., Nam K.-H et al. Phenotypic changes in peripheral blood monocytes of cynomolgus monkeys acutely infected with simian immunodeficiency virus. AIDS Res Human Retrovir 1998;14:1181-6.[Web of Science][Medline] [Order article via Infotrieve]
  • Averill LE, Meagher RC, Gerrity RG Enhanced monocyte progenitor cell proliferation in bone marrow of hyperlipemic swine. American Journal of Pathology 1989;135(2):369-77.[Abstract]
  • RotheG.,HerrAS,StohrJ.,AbletshauserC.,WeidingerG.,SchmitzG. Amoremature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease. Atherosclerosis 1999;144(1):251-61.[CrossRef][Medline] [Order article via Infotrieve]
  • Banda MA, Lefer DJ, Granger DN Postischemic endothelium-dependent vascular reactivity is preserved in adhesion molecule-deficient mice. American Journal of Physiology 1997;273(6 Pt 2):H2721-5.[Web of Science][Medline] [Order article via Infotrieve]
  • Noble KE, Panayiotidis P., Collins PW, Hoffbrand AV,Yong KL Monocytes induce E-selectin gene expression in endothelial cells: role of CD11b/CD18 and extracellular matrix proteins. European Journal of Immunology 1996; 26(12):2944-51.1.[Web of Science][Medline] [Order article via Infotrieve]
  • Rothe G., Gabriel H., Kovacs E. et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterio Thromb Vasc Biol 1996;16:1437-47.[Abstract/Free Full Text]
  • Lehr HA,Vollmar B.,Vajkoczy P., Menger MD Intravital fluorescence microscopy for the study of leukocyte interaction with platelets and endothelial cells. Oxidants and Antioxidants, PT B 1999;300:462-481.[CrossRef][Web of Science]
  • Serrano CVJ, Ramires JA, Venturinelli M. et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. Journal of the American College of Cardiology 1997;29(6):1276-83.[Abstract]
  • de Servi S., Mazzone A., Ricevuti G. et al. Expression of neutrophil and monocyte CD11b/CD18 adhesion molecules at different sites of the coronary tree in unstable angina pectoris. American Journal of Cardiology 1996;78(5):564-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rovers C., Netea MG, de Bont N. et al. LPS-induced cytokine production and expression of beta2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia. Atherosclerosis 1998;141(1):99-105.[CrossRef][Medline] [Order article via Infotrieve]
  • Weber C., Erl W., Weber KS, Weber PC HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. Journal of the American College of Cardiology 1997;30(5):1212-7.[Abstract]
  • Keidar S.,Attias J., Heinrich R., Coleman R., Aviram M.Angiotensin II atherogenicity in apolipoprotein E-deficient mice is associated with increased cellular cholesterol biosynthesis. Atherosclerosis 1999;146(2):249-57.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Weber KT, Swamynathan SK, Guntaka RV, Sun Y. Angiotensin II and extracellular matrix homeostasis. International Journal of Biochemistry & Cell Biology 1999;31(3-4):395-403.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Haznedaroglu IC A local renin--angiotensin system in the bone marrow: hypothesis and clues. Experimental Hematology 1999;27(1):186-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • del Castillo D., Campistol JM, Guirado L. et al. Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients. Kidney International - Supplement 1998;68:S135-9.[Medline] [Order article via Infotrieve]
  • Wulf GG, Jahns-Streubel G., Strutz F. et al. Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells. Annals of Hematology 1996;73(3):139-41.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mrug M., Stopka T., Julian BA, Prchal JF, Prchal JT. Angiotensin II stimulates proliferation of normal early erythroid progenitors. Journal of Clinical Investigation 1997;1;100(9):2310-4.[Web of Science][Medline] [Order article via Infotrieve]
  • Farokhzad OC, Shelley CS,Arnaout MA Induction of the CD11b gene during activation of the monocytic cell line U937 requires a novel nuclear factor MS-2. Published erratum appears in J Immunol 1999; 15;163(2):1091.
  • Anderson KL, Smith KA, Perkin H. et al. PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation. Blood 1999; 1;94(7):2310-8.[Abstract/Free Full Text]
  • Klahr S., Morrissey J. Angiotensin II and gene expression in the kidney. American Journal of Kidney Diseases 1998;31(1):171-6.[Web of Science][Medline] [Order article via Infotrieve]
  • Papayannopoulou T., Craddock C. Homing and trafficking of hemopoietic progenitor cells. Acta Haematologica 1997;97(1-2):97.[Web of Science][Medline] [Order article via Infotrieve]
  • Wilkins BS, Jones DB Cell-stroma interactions in monocytopoiesis. FEMS Microbiology Immunology 1992;5(5-6):347-53.[Medline] [Order article via Infotrieve]
  • Nabeshima R.,Aizawa S., Nakano M. et al. Effects of vesnarinone on the bone marrow stromal cell-dependent proliferation and differentiation of HL60 cells in vitro. Experimental Hematology 1997;25(6):509-15.[Web of Science][Medline] [Order article via Infotrieve]
  • McKercher SR, Henkel GW, Maki RAThe transcription factor PU.1 does not regulate lineage commitment but has lineage-specific effects. Journal of Leukocyte Biology 1999;66(5):727-732.[Abstract]
  • Berk BC Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases. Journal of the American Society of Nephrology 1999;10 (Suppl 11):S62-8.[Web of Science][Medline] [Order article via Infotrieve]
  • Nakano N., Moriguchi A., Morishita R. et al. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats. Hypertension 1997;30(6):1448-54.[Abstract/Free Full Text]
  • Matsumoto K., Morishita R., Moriguchi A. et al. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats. Hypertension 1999;34(2):279-84.[Abstract/Free Full Text]
  • Morishita R.,Aoki M., Nakamura S. et al. Potential role of a novel vascular modulator, hepatocyte growth factor (HGF), in cardiovascular disease: characterization and regulation of local HGF system. Journal of Atherosclerosis & Thrombosis 1997;4(1):12-9.
  • Aoyagi M.,Yamamoto S.,Azuma H. et al. Localization and effects of hepatocyte growth factor on smooth muscle cells during neointimal formation after balloon denudation. Histochemistry & Cell Biology 1999;111(6):419-28.[CrossRef]
  • Yoshimura M., Sakurabayashi I. Introductory review of diagnostic approach to arteriosclerosis. Rinsho Byori: Japanese Journal of Clinical Pathology 1998; 46(7):663-5.
  • Tomida M., Heike T., Yokota T. Cytoplasmic domains of the leukemia inhibitory factor receptor required for STAT3 activation, differentiation, and growth arrest of myeloid leukemic cells. Blood 1999; 15;93(6):1934-41.[Abstract/Free Full Text]
  • Phillips MI, Mohuczy-Dominiak D., Coffey M. et al. Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense. Hypertension 1997; 29(1 Pt 2):374-80.[Abstract/Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 1, 11-17 (2000)
DOI: 10.3317/jraas.2000.001
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Sanchez-Lemus, J. Benicky, J. Pavel, I. M. Larrayoz, J. Zhou, M. Baliova, T. Nishioku, and J. M. Saavedra
Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1376 - R1384.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. Bregonzio, I. Armando, H. Ando, M. Jezova, G. Baiardi, and J. M. Saavedra
Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury
Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G414 - G423.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Strawn, W. B
Right arrow Articles by Ferrario, C. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strawn, W. B
Right arrow Articles by Ferrario, C. M
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement